MX2019004345A - Formas cristalinas de 4-(2-((1r,2r)-2-hidroxiciclohexilamino) benzotiazol-6-iloxi)-n-metilpicolinamida. - Google Patents
Formas cristalinas de 4-(2-((1r,2r)-2-hidroxiciclohexilamino) benzotiazol-6-iloxi)-n-metilpicolinamida.Info
- Publication number
- MX2019004345A MX2019004345A MX2019004345A MX2019004345A MX2019004345A MX 2019004345 A MX2019004345 A MX 2019004345A MX 2019004345 A MX2019004345 A MX 2019004345A MX 2019004345 A MX2019004345 A MX 2019004345A MX 2019004345 A MX2019004345 A MX 2019004345A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- hydroxycyclohexylamino
- benzothiazol
- yloxy
- methylpicolinamide
- Prior art date
Links
- ADZBMFGQQWPHMJ-RHSMWYFYSA-N 4-[[2-[[(1r,2r)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=C3SC(N[C@H]4[C@@H](CCCC4)O)=NC3=CC=2)=C1 ADZBMFGQQWPHMJ-RHSMWYFYSA-N 0.000 title 1
- IHWOVMRZEIHNGY-SATBOSKTSA-N 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide hydrochloride Chemical class Cl.O[C@H]1[C@@H](CCCC1)NC=1SC2=C(N1)C=CC(=C2)OC2=CC(=NC=C2)C(=O)NC IHWOVMRZEIHNGY-SATBOSKTSA-N 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000005017 glioblastoma Diseases 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000002528 pancreatic cancer Diseases 0.000 abstract 1
- 208000008443 pancreatic carcinoma Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662408358P | 2016-10-14 | 2016-10-14 | |
| PCT/IB2017/056379 WO2018069892A1 (en) | 2016-10-14 | 2017-10-13 | Crystalline forms of 4-(2-((1r,2r)-2-hydroxycyclohexylamino) benzothiazol-6-yloxy)-n-methylpicolinamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019004345A true MX2019004345A (es) | 2019-07-01 |
Family
ID=60320932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019004345A MX2019004345A (es) | 2016-10-14 | 2017-10-13 | Formas cristalinas de 4-(2-((1r,2r)-2-hidroxiciclohexilamino) benzotiazol-6-iloxi)-n-metilpicolinamida. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10934273B2 (enExample) |
| EP (1) | EP3526217B1 (enExample) |
| JP (1) | JP7068288B2 (enExample) |
| KR (1) | KR20190064589A (enExample) |
| CN (1) | CN109843880B (enExample) |
| AU (1) | AU2017342239B2 (enExample) |
| BR (1) | BR112019006914A2 (enExample) |
| CA (1) | CA3039764A1 (enExample) |
| CL (1) | CL2019001008A1 (enExample) |
| ES (1) | ES2949414T3 (enExample) |
| IL (1) | IL265893A (enExample) |
| MX (1) | MX2019004345A (enExample) |
| RU (1) | RU2019114208A (enExample) |
| WO (1) | WO2018069892A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
| KR20220130698A (ko) * | 2019-12-20 | 2022-09-27 | 에피자임, 인코포레이티드 | Ezh2 억제제의 결정질 하이드로브로마이드 염, 이의 제조 및 암의 치료에 유용한 약학적 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101432281B (zh) * | 2006-04-19 | 2013-08-28 | 诺瓦提斯公司 | 6-0-取代的苯并*唑和苯并噻唑化合物以及抑制csf-1r信号传导的方法 |
| KR101464385B1 (ko) * | 2006-04-19 | 2014-11-21 | 노파르티스 아게 | ６-ｏ-치환된 벤즈옥사졸 및 벤조티아졸 화합물, 및 ｃｓｆ-１ｒ 신호전달의 억제 방법 |
| SI2704713T1 (sl) * | 2011-05-05 | 2017-05-31 | Novartis Ag | CSF-1R inhibitorji za zdravljenje možganskih tumorjev |
| EP3233918A1 (en) * | 2014-12-19 | 2017-10-25 | Novartis AG | Combination therapies |
-
2017
- 2017-10-13 CN CN201780063254.XA patent/CN109843880B/zh active Active
- 2017-10-13 WO PCT/IB2017/056379 patent/WO2018069892A1/en not_active Ceased
- 2017-10-13 US US16/341,124 patent/US10934273B2/en active Active
- 2017-10-13 EP EP17797745.1A patent/EP3526217B1/en active Active
- 2017-10-13 AU AU2017342239A patent/AU2017342239B2/en not_active Ceased
- 2017-10-13 BR BR112019006914A patent/BR112019006914A2/pt not_active IP Right Cessation
- 2017-10-13 JP JP2019520040A patent/JP7068288B2/ja not_active Expired - Fee Related
- 2017-10-13 RU RU2019114208A patent/RU2019114208A/ru not_active Application Discontinuation
- 2017-10-13 ES ES17797745T patent/ES2949414T3/es active Active
- 2017-10-13 KR KR1020197010527A patent/KR20190064589A/ko not_active Ceased
- 2017-10-13 MX MX2019004345A patent/MX2019004345A/es unknown
- 2017-10-13 CA CA3039764A patent/CA3039764A1/en not_active Abandoned
-
2019
- 2019-04-07 IL IL265893A patent/IL265893A/en unknown
- 2019-04-12 CL CL2019001008A patent/CL2019001008A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017342239A1 (en) | 2019-04-18 |
| EP3526217A1 (en) | 2019-08-21 |
| ES2949414T3 (es) | 2023-09-28 |
| AU2017342239B2 (en) | 2020-05-28 |
| CA3039764A1 (en) | 2018-04-19 |
| WO2018069892A1 (en) | 2018-04-19 |
| JP2019530719A (ja) | 2019-10-24 |
| BR112019006914A2 (pt) | 2019-07-02 |
| CN109843880B (zh) | 2023-12-01 |
| KR20190064589A (ko) | 2019-06-10 |
| CL2019001008A1 (es) | 2019-06-21 |
| US10934273B2 (en) | 2021-03-02 |
| JP7068288B2 (ja) | 2022-05-16 |
| RU2019114208A (ru) | 2020-11-16 |
| IL265893A (en) | 2019-06-30 |
| EP3526217B1 (en) | 2023-04-19 |
| RU2019114208A3 (enExample) | 2020-11-18 |
| US20200190057A1 (en) | 2020-06-18 |
| CN109843880A (zh) | 2019-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA519401020B1 (ar) | مركبات n-(فينيل سلفونيل)بنزاميد والمركبات ذات الصلة كمثبطات لبروتين ليمفوما الخلية البائية 2 | |
| MX2021001091A (es) | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington. | |
| MX2022005290A (es) | Compuestos heterociclicos como inmunomoduladores. | |
| EA201790376A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| EA201692513A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| PH12019501350B1 (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
| EA201891526A2 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| MY199220A (en) | Heterocyclic compounds as immunomodulators | |
| PH12019501896A1 (en) | Therapeutic dendrimers | |
| MX2015013481A (es) | Compuestos heterociclicos fusionados como inhibidores de proteina quinasa. | |
| PH12015501868A1 (en) | Inhibitors of histone demethylases | |
| PH12016502394A1 (en) | 1, 3, 4-thiadiazole compounds and their use in treating cancer | |
| EA201791516A1 (ru) | Способы комбинированного лечения злокачественных опухолей | |
| EA201790082A1 (ru) | Ингибиторы лизин-специфической демитилазы-1 | |
| EA201692483A1 (ru) | Ингибиторы гистоновой метилазы | |
| PH12018500315A1 (en) | Fumagillol heterocyclic compounds and methods of making and using same | |
| MX390051B (es) | Antagonistas de ep4. | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201700356A1 (ru) | Новые циклопропанбензофуранилпиридопиразиндионы | |
| MX2016008968A (es) | Compuestos organicos. | |
| EA201892311A1 (ru) | Производные 2-анилинопиримидина в качестве терапевтических агентов для лечения рака мозга | |
| MX2018004696A (es) | Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos. | |
| EA202190045A1 (ru) | Составы/композиции, содержащие ибрутиниб | |
| BR112019006914A2 (pt) | formas cristalinas de 4-(2-((1r,2r)-2-hidroxiciclo-hexilamino)benzotiazol-6-ilóxi)-n-metilpicolinamida | |
| PH12017501134A1 (en) | Fumagillol derivatives |